Published in Carcinogenesis on July 10, 2013
Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study. Int J Cancer (2016) 1.09
Oral bacteria and cancer. PLoS Pathog (2014) 1.05
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget (2015) 0.94
Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget (2015) 0.94
Obesity and cancer pathogenesis. Ann N Y Acad Sci (2014) 0.93
Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol (2014) 0.90
LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4. Dig Dis Sci (2014) 0.84
Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer (2016) 0.83
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol (2014) 0.81
Helicobacter pylori infection: new pathogenetic and clinical aspects. World J Gastroenterol (2014) 0.80
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol (2016) 0.79
Oral environment and cancer. Genes Environ (2016) 0.79
Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol (2015) 0.78
Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cell Microbiol (2016) 0.76
The role of the histoblood ABO group in cancer. Future Sci OA (2016) 0.75
Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol (2017) 0.75
Oral bacteria in pancreatic cancer: mutagenesis of the p53 tumour suppressor gene. Int J Clin Exp Pathol (2015) 0.75
Progress in oral personalized medicine: contribution of 'omics'. J Oral Microbiol (2015) 0.75
The potential role of microbes in oncogenesis with particular emphasis on oral cancer. Saudi Med J (2016) 0.75
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer. Carcinogenesis (2016) 0.75
Periodontal Pathogens in the Etiology of Pancreatic Cancer. Gastrointest Tumors (2016) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Cigarette smoking and infection. Arch Intern Med (2004) 5.04
ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72
Toll-like receptors and cancer. Nat Rev Cancer (2008) 4.29
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23
The pancreas cancer microenvironment. Clin Cancer Res (2012) 4.10
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45
microRNA involvement in human cancer. Carcinogenesis (2012) 2.98
Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet (2008) 2.85
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer (2011) 2.59
A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst (2007) 2.40
Periodontal diseases: epidemiology. Ann Periodontol (1996) 2.34
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 2.32
Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst (2003) 2.23
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21
Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev (2009) 2.07
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med (2012) 1.82
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res (2010) 1.82
Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res (2004) 1.72
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol (2011) 1.71
An exploration of the periodontitis-cancer association. Ann Epidemiol (2003) 1.59
ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst (2010) 1.54
Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis (2012) 1.50
Association between Helicobacter pylori infection and pancreatic cancer. Oncology (1998) 1.49
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol (2009) 1.46
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J Clin Invest (2012) 1.45
Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol (2010) 1.44
The impact of obesity on the immune response to infection. Proc Nutr Soc (2012) 1.41
Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem (2009) 1.35
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Tooth loss, pancreatic cancer, and Helicobacter pylori. Am J Clin Nutr (2003) 1.35
Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut (2012) 1.32
Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas (1994) 1.28
A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer (2011) 1.25
Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol (1999) 1.24
Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One (2012) 1.19
Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med (1997) 1.19
Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect Immun (2011) 1.18
Diabetes and infection: is there a link?--A mini-review. Gerontology (2012) 1.16
Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J Periodontal Res (2006) 1.14
Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.11
Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol (2005) 1.11
Validity of a self-reported periodontal disease measure. J Public Health Dent (1996) 1.09
A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer (2008) 1.07
Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog (2012) 1.07
Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. World J Gastroenterol (2010) 1.06
Quantitative relationship between oral nitrate-reducing activity and the endogenous formation of N-nitrosoamino acids in humans. Food Chem Toxicol (1991) 1.05
Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J Surg Oncol (2009) 1.05
ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer (2011) 1.04
Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol (1996) 1.03
Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP (2011) 1.03
Toll-like receptors and diabetes: a therapeutic perspective. Clin Sci (Lond) (2012) 1.02
Determinants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol (2010) 0.97
Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer (2012) 0.96
MicroRNAs and toll-like receptor/interleukin-1 receptor signaling. J Hematol Oncol (2012) 0.95
Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences. Future Microbiol (2013) 0.94
The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int J Cancer (2007) 0.89
History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology (2009) 0.85
Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes (2011) 0.83